Novosti
Khirurgii
This journal is
indexed in Scopus









Year 2017 Vol. 25 No 1

ONCOLOGY

DOI: https://dx.doi.org/10.18484/2305-0047.2017.1.60   |  

U.U. ANDRUSHCHUK1, Y.P. OSTROVSKY1,2, V.V. ZHARKOV1, A.V. VALENTSIUKEVICH1, L.G. SHESTAKOVA1,2, O.A. YUDINA3, T.V. ILYINA1, S.G. OMELTSCHENKO1, S.A. KURGANOVICH1, A.Z. SMOLENSKY3

SURGICAL TREATMENT OF PATIENTS WITH PRIMARY MALIGNANT TUMORS OF THE HEART

SE "Republican Scientific Practical Centre Cardiology" 1,
SEE "Belarusian Medical Academy of Post-graduate Education" 2,
ME "City Clinical Pathology Bureau" 3,
Minsk,
The Republic of Belarus

Objectives. To evaluate the results of surgical treatment of patients with primary malignant tumors of the heart (PMTH).
Methods. Within the period from 2001 to 2015 11 patients (5 men, 6 women, mean age 50,718,1 years) had undergone surgical resection of primary malignant cardiac tumor in RSPC Cardiology. PMTH was located in the left side of the heart in seven patients, in the right side in three, in both right and left sides in one patient.
Results. Three operations of the heart autotransplantation (HA), one orthotopic heart transplantation (OHT), three radical resections of the tumor in situ (RRT) and four cytoreductive interventions (CRI) had been performed. Average time of myocardial ischemia was 119,920,2 min, artificial circulation 178,131,9 min., average blood loss 1601,8367,3 ml. Major hospital complications (MHC) occurred in six patients. Three patients died due to the non-cardiac causes in the hospital period. The observation period was 467,0100,3 days. Seven patients (one withdrew) died due to disease progression or relapse. Recurrence-free survival was 456,8103,0 days, the average duration up to the outcome 357,6121,6 days. The survival of patients after radical surgeries (RS) 565,4112,2 days, discharged from the center, was 2,5 fold higher than in CRI patients 221,028,0 days.
Conclusion. Primary malignant tumors of the heart is a rare pathology with almost fatal prognosis, late detectability and unsatisfactory results of treatment. Radical surgeries (RS) RRT, HA, OHT as a part of a multimodal treatment are considered to be a current therapeutic strategy of PMTH (except lymphoma). MHC-rate and hospital mortality after RS are high. Relapse or disease progression was the cause of death in all patients within the period of observation. Radical operations and in the case of inability of their performance the cytoreductive operations comprising a multimodal therapy can reduce symptoms and prolong life.

Keywords: primary cardiac tumors, surgery, sarcoma, lymphoma, multimodal therapy, recurrence, mortality
p. 60-70 of the original issue
References
  1. Lobo A, Lewis JF, Conti CR. Intracardiac masses detected by echocardiography: case presentations and review of the literature. Clin Cardiol. 2000 Sep;23(9):702-8.
  2. Arif R, Eichhorn F, Kallenbach K, Seppelt P, Ruhparwar A, Dienemann H, et al. Resection of thoracic malignancies infiltrating cardiac structures with use of cardiopulmonary bypass. J Cardiothorac Surg. 2015 Jun 25;10:87. doi: 10.1186/S13019-015-0296-8.
  3. Rice DC, Reardon MJ. Left heart sarcomas. Methodist Debakey Cardiovasc J. 2010 Jul-Sep;6(3):49-56.
  4. Inoue T, Koyama K, Oriuchi N, Alyafei S, Yuan Z, Suzuki H, et al. Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG--preliminary study. Radiology. 2001 Jul;220(1):54-62.
  5. Abramowitz Y, Hiller N, Perlman G, Admon D, Beeri R, Chajek-Shaul T, et al. The diagnosis of primary cardiac lymphoma by right heart catheterization and biopsy using fluoroscopic and transthoracic echocardiographic guidance. Int J Cardiol. 2007 May 31;118(2):e39-40.
  6. Talbot SM, Taub RN, Keohan ML, Edwards N, Galantowicz ME, Schulman LL. Combined heart and lung transplantation for unresectable primary cardiac sarcoma. J Thorac Cardiovasc Surg. 2002 Dec;124(6):1145-8.
  7. Blackmon SH, Patel A, Reardon MJ. Management of primary cardiac sarcomas. Expert Rev Cardiovasc Ther. 2008 Oct;6(9):1217-22. doi: 10.1586/14779072.6.9.1217.
  8. Kamiya H, Yasuda T, Nagamine H, Sakakibara N, Nishida S, Kawasuji M, et al. Surgical treatment of primary cardiac tumors: 28 years' experience in Kanazawa University Hospital. Jpn Circ J. 2001 Apr;65(4):315-9.
  9. Habertheuer A, Laufer G, Wiedemann D, Andreas M, Ehrlich M, Rath C, et al. Primary cardiac tumors on the verge of oblivion: a European experience over 15 years. J Cardiothorac Surg. 2015 Apr 18;10:56. doi: 10.1186/S13019-015-0255-4.
  10. Pirk J, Maly J, Szarszoi O, Urban M, Kotulak T, Riha H, et al. Total artificial heart support with two continuous-flow ventricular assist devices in a patient with an infiltrating cardiac sarcoma. ASAIO J. 2013 Mar-Apr;59(2):178-80. doi: 10.1097/MAT.0b013e3182816cd9.
  11. Orlandi A, Ferlosio A, Roselli M, Chiariello L, Spagnoli LG. Cardiac sarcomas: an update. J Thorac Oncol. 2010 Sep;5(9):1483-9. doi: 10.1097/JTO.0b013e3181e59a91.
  12. Jeudy J, Kirsch J, Tavora F, Burke AP, Franks TJ, Mohammed TL, et al. From the radiologic pathology archives: cardiac lymphoma: radiologic-pathologic correlation. Radiographics. 2012 Sep-Oct;32(5):1369-80. doi: 10.1148/rg.325115126.
  13. Turbendian H, Seastedt KP, Shavladze N, Port J, Altorki N, Stiles B, et al. Extended resection of sarcomas involving the mediastinum: a 15-year experience. Eur J Cardiothorac Surg. 2016 Mar;49(3):829-34. doi: 10.1093/ejcts/ezv222.
Address for correspondence:
220036, the Republic of Belarus, Minsk,
Rosa Luxemburg str., 110,
The Republican Scientific and
Practical Center Cardiology, Laboratory
of heart surgery,
Tel: +375 17 2088605
E-mail: heartslight@mail.ru,
Vladimir V. Andruschuk
Information about the authors:
Andrushchuk U.U. PhD, Cardiac surgeon of cardiac surgery unit N2, SE "Republican Scientific Practical Centre Cardiology".
Ostrovsky Y.P. MD, Professor, Academician of NAS of Belarus, Head of department of cardiac surgery, SEE "Belarusian Medical Academy of Post-graduate Education", Chief Freelance cardiac surgeon Ministry of Health of the Republic of Belarus.
Zharkov V.V. MD, Professor, Head of surgical unit of thoracic oncopathology with the group of anesthesiology, SE "Republican Scientific and Practical Center of Oncology and Medical Radiology named after N.N.Alexandrov".
Valentsiukevich A.V. Head of anesthesiology and intensive care unit, SE "Republican Scientific Practical Centre Cardiology".
Shestakova L.G. MD, Head of extracorporeal circulation unit, SE "Republican Scientific Practical Centre Cardiology", lecturer of cardiac surgery department, SEE "Belarusian Medical Academy of Post-graduate Education".
Yudina O.A. PhD, Ass. Professor, Head of general pathology unit N1, ME "City Clinical Pathology Bureau", Ass. Professor of pathologic anatomy department, EE "Belarusian State Medical University".
Ilyina T.V. Head of X-ray unit, SE "Republican Scientific Practical Centre Cardiology".
Omeltschenko S.G. Clinical intern (cardiac surgery), SE "Republican Scientific Practical Centre Cardiology".
Kurganovich S.A. Physician (ultrasound diagnostics), SE "Republican Scientific Practical Centre Cardiology", fellow-worker of heart surgery laboratory.
Smolensky A.Z. Pathologist of general pathology unit N1, ME "City Clinical Pathology Bureau".
Contacts | ©Vitebsk State Medical University, 2007